| For: | Lubián López DM. Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World J Clin Oncol 2022; 13(2): 71-100 [PMID: 35316932 DOI: 10.5306/wjco.v13.i2.71] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v13/i2/71.htm |
| Number | Citing Articles |
| 1 |
Ishrat Hussain, Vikram Sinai Talaulikar. A systematic review of randomised clinical trials – The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors. Post Reproductive Health 2023; 29(4) doi: 10.1177/20533691231208473
|
| 2 |
Manon Mangiardi-Veltin, Delphine Hequet, Carine Segura-Djezzar, Roman Rouzier, Claire Bonneau. Sexuality after breast cancer, how to provide a global and contemporary approach. Bulletin du Cancer 2023; 110(1) doi: 10.1016/j.bulcan.2022.10.002
|
| 3 |
Tao Liu, Chao Lin, Hui Shi, Qiang Ren, Xinmei Lin. Knowledge, attitude, and practice towards knee osteoarthritis: a regional study in Chinese patients. Clinical Rheumatology 2025; 44(4) doi: 10.1007/s10067-025-07385-0
|
| 4 |
Sara Perelmuter, Aimee Osgood, Nicole Munoz, Anna Myers, Louise Newson, Rachel Pope, Rachel S. Rubin, Heather Quaile. Redefining genitourinary syndrome: A proposal to expand the GSM nomenclature to encompass the full spectrum of hypoestrogenic and hypoandrogenic urogenital disorders. Maturitas 2026; 212 doi: 10.1016/j.maturitas.2026.109083
|
| 5 |
Aniele Tomadon, Jaqueline Lemos de Oliveira, Isabella Queren de Oliveira, Thais de Oliveira Gozzo. Genitourinary symptoms and quality of life of women with breast cancer undergoing chemotherapy. Fisioterapia e Pesquisa 2023; 30 doi: 10.1590/1809-2950/e23001823en
|
| 6 |
Serpil Abalı Çetin. Managing Side Effects of Breast Cancer Treatment. 2024; doi: 10.1007/978-3-031-75480-7_25
|
| 7 |
Apisith Saraluck, Tharin Phenwan, Thanarpan Peerawong. Genitourinary syndrome of menopause among breast cancer survivors: an untold story. Gynecology and Obstetrics Clinical Medicine 2025; 5(3) doi: 10.1136/gocm-2024-000089
|
| 8 |
Franklin José Espitia De La Hoz. Eficacia y seguridad del promestrieno en el tratamiento del síndrome genitourinario de la menopausia en mujeres con cáncer de mama. Universitas Médica 2024; 65 doi: 10.11144/Javeriana.umed65.espt
|
| 9 |
Rui Dong, Kegao Liu, Xin Shen, Hua Sun. Menopausal Status, Hormone Replacement Therapy, and Epiphora Symptoms Among Middle-Aged and Older US Women: An NHANES Study. Ophthalmic Plastic & Reconstructive Surgery 2026; doi: 10.1097/IOP.0000000000003229
|
| 10 |
Vittoria Benini, Alessandro Ruffolo, Arianna Casiraghi, Rebecca Degliuomini, Matteo Frigerio, Andrea Braga, Maurizio Serati, Marco Torella, Massimo Candiani, Stefano Salvatore. New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review. Medicina 2022; 58(6) doi: 10.3390/medicina58060770
|
| 11 |
Solveig K. Smedsland, Kathrine F. Vandraas, Ragnhild S. Falk, Julie Horn, Randi J. Reidunsdatter, Cecilie E. Kiserud, Alv A. Dahl, Mette Brekke, Kristin V. Reinertsen. Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study. Breast Cancer Research and Treatment 2023; 201(3) doi: 10.1007/s10549-023-07021-y
|
| 12 |
María Jesús Cancelo Hidalgo, Llaura Barrera Coello. Menopause. 2025; doi: 10.1007/978-3-031-83979-5_6
|
| 13 |
Nicoli Serquiz, Ayane Cristine Alves Sarmento, Antonio Carlos Queiroz de Aquino, Natalie Rios Almeida, Maria Luísa Nobre, Juliana Dantas de Araújo Santos Camargo, Kleyton Santos de Medeiros, Ana Katherine Gonçalves. Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: A systematic review of randomized controlled trial. International Journal of Gynecology & Obstetrics 2026; 173(1) doi: 10.1002/ijgo.70665
|
| 14 |
Barbara Campos Martin, Caroline Nakano VItorino, Rafaela Souza, Natalia Medolago, Georgia Petri Nahas, Eduardo Carvalho-Pessoa, Heloisa De Luca Vespoli, Eliana Aguiar Petri Nahas. Effect of a non-hormonal vaginal moisturizer on vaginal and vulvar health in postmenopausal women with breast cancer: A randomized clinical trial. Maturitas 2026; 207 doi: 10.1016/j.maturitas.2026.108880
|
| 15 |
S. Salvatore, A. F. Ruffolo, C. Phillips, S. Athanasiou, L. Cardozo, M. Serati. Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser. Climacteric 2023; 26(4) doi: 10.1080/13697137.2023.2225766
|
| 16 |
Clara Elia, Joy Perrier, Mylène Duivon, Stéphane Rehel, François Gernier, Marie Fernette, Franck Doidy, Patrice Clochon, Jean-Michel Grellard, François Christy, Carine Segura-Djezzar, Julien Geffrelot, George Emile, Djelila Allouache, Fausto Viader, Christelle Lévy, Florence Joly, Francis Eustache, Bénédicte Giffard. Links between nocturnal hypoxia and cognitive function in breast cancer. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-26591-z
|
| 17 |
Laura Cucinella, Lara Tiranini, Chiara Cassani, Silvia Martella, Rossella E Nappi. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy. International Journal of Women's Health 2023; doi: 10.2147/IJWH.S414509
|
| 18 |
Daniel M. Lubián-López, Carmen A. Butrón-Hinojo, Salomón Menjón-Beltrán, Ernesto González-Mesa, Silvia Tapiador-Albertos, Bibiana Rodríguez-Jiménez, Gabriel Fiol-Ruiz. Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. Journal of Clinical Medicine 2023; 12(17) doi: 10.3390/jcm12175669
|
| 19 |
Mária Faltinová, Leena Vehmanen, Heli Lyytinen, Hanna Savolainen-Peltonen, Anni Virtanen, Mikko Haanpää, Esa Hämäläinen, Aila Tiitinen, Johanna Mattson. Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. Breast Cancer Research and Treatment 2025; 210(2) doi: 10.1007/s10549-024-07564-8
|
| 20 |
Ana Borobia Pérez, Javier Estévez Espejo, María Jiménez-González, Roger García López. Vulvovaginal Collagen Injection as a Regenerative Strategy in Genitourinary Syndrome of Menopause: Results of a Pilot Study. Journal of Clinical Medicine 2026; 15(4) doi: 10.3390/jcm15041408
|
| 21 |
Olivia Mihulka, Melissa Curran, Raksha M. Narasimhan, Jessica F. Moore, Kristin E. Rojas. Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer. Journal of Minimally Invasive Gynecology 2026; 33(7) doi: 10.1016/j.jmig.2025.12.021
|
| 22 |
Caroline Nakano Vitorino, Michelle Sako Omodei, Rafaela Caroline de Souza, Georgia Petri Nahas, Daniel de Araujo Brito Buttros, Eduardo Carvalho-Pessoa, Heloisa De Luca Vespoli, Eliana Aguiar Petri Nahas. Assessment of sexual function in postmenopausal breast cancer survivors. Sexual Medicine 2024; 12(3) doi: 10.1093/sexmed/qfae035
|
| 23 |
Qiancheng Mao, Tong Cai, Haijuan Li, Yongli Chu, Yuanshan Cui, Jitao Wu. The efficacy of CO2 laser in the treatment of genitourinary syndrome of menopause: a systematic review and meta-analysis of randomized controlled trials. Lasers in Medical Science 2023; 38(1) doi: 10.1007/s10103-023-03808-z
|
| 24 |
I. Lázaro-Navas, B. Mur-Molina, E.B. Villalobos-Baeza, A. Cortés-Salgado, R.Hernández Pailos, E.M. Díaz-Soto, T.E. Fernández-Pardo, L. López-González, D. Valcárcel-Linares. Effectiveness of radiofrequency therapy combined with pelvic floor muscle training in breast cancer survivors with genitourinary syndrome of menopause: a study protocol. European Journal of Obstetrics & Gynecology and Reproductive Biology 2026; 320 doi: 10.1016/j.ejogrb.2026.115010
|
| 25 |
A. G. Solopova, J. Kh. Khizroeva, O. S. Gridasova, V. O. Bitsadze, A. E. Ivanov, V. N. Galkin, A. D. Makatsariya. Neutrophil extracellular trap biomarkers as indicators of vulvovaginal atrophy severity after cancer treatment. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 2026; 18(4) doi: 10.17749/2070-4909/farmakoekonomika.2025.350
|
| 26 |
Bernadeta A. Pietrzak, Agnieszka Wnuk, Karolina Przepiórska, Andrzej Łach, Małgorzata Kajta. Posttreatment with Ospemifene Attenuates Hypoxia- and Ischemia-Induced Apoptosis in Primary Neuronal Cells via Selective Modulation of Estrogen Receptors. Neurotoxicity Research 2023; 41(4) doi: 10.1007/s12640-023-00644-5
|
| 27 |
Linda Cucciniello, Federica Miglietta, Valentina Guarneri, Fabio Puglisi. Managing sexual health challenges in breast cancer survivors: A comprehensive review. The Breast 2024; 76 doi: 10.1016/j.breast.2024.103754
|
| 28 |
Kevan Richard Wylie, Michael G Kirby, Filippo Maria Nimbi, Michael Krychman, Jennifer Barsky Reese, Deborah C Marshall. Sexual function in chronic illness and cancer perspectives of the patient, partner, and healthcare provider; innovations; and updates: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sexual Medicine Reviews 2026; 14(1) doi: 10.1093/sxmrev/qeag002
|
| 29 |
Tia Tafla, Abinaya Balasubramanian, Janaki K. Iyer. Exploring the Potential of Biotics in Cancer Prevention and Treatment—Mechanisms, Experimental, and Clinical Insights. Onco 2025; 5(3) doi: 10.3390/onco5030041
|
| 30 |
Nida Jugulytė, Guoda Žukienė, Daiva Bartkevičienė. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review. Medicina 2023; 59(1) doi: 10.3390/medicina59010132
|
| 31 |
Stefano Salvatore, Vittoria Benini, Alessandro Ferdinando Ruffolo, Rebecca S. Degliuomini, Anna Redaelli, Arianna Casiraghi, Massimo Candiani. Current challenges in the pharmacological management of genitourinary syndrome of menopause. Expert Opinion on Pharmacotherapy 2023; 24(1) doi: 10.1080/14656566.2022.2152326
|
| 32 |
Svetlana Jankovic, Marija Rovcanin, Ana Tomic, Aleksandar Jurisic, Zagorka Milovanovic, Milena Zamurovic. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024; 60(7) doi: 10.3390/medicina60071059
|
| 33 |
Victoria Kershaw, Swati Jha. Practical Guidance on the Use of Vaginal Laser Therapy: Focus on Genitourinary Syndrome and Other Symptoms. International Journal of Women's Health 2024; doi: 10.2147/IJWH.S446903
|
| 34 |
Aniele Tomadon, Jaqueline Lemos de Oliveira, Isabella Queren de Oliveira, Thais de Oliveira Gozzo. Sintomas geniturinários e qualidade de vida de mulheres com câncer de mama em tratamento quimioterápico. Fisioterapia e Pesquisa 2023; 30 doi: 10.1590/1809-2950/e23001823pt
|
| 35 |
Annabelle Huguenin. Menopausal hormone therapy for breast cancer survivors. Current Opinion in Obstetrics & Gynecology 2025; 37(1) doi: 10.1097/GCO.0000000000001001
|
| 36 |
Isaac Melo MD, Dolores Escobedo MSN, Karla Aguilar MD, Wendy Aguilar MD, Yazzmin Ballesteros MD, Carlos Durazo MD, Omar Guerrero MD. Treatment of sexual dysfunction, with platelet rich plasma in woman cancer survivors. Obstetrics & Gynecology International Journal 2024; 15(3) doi: 10.15406/ogij.2024.15.00746
|
| 37 |
Laura Ferreira de Rezende, Vanessa Fonseca Vilas Boas, Juliana Lenzi, Regiane Luz Carvalho. Evidencias sobre el Uso de la Fotobiomodulación para la Disfunción Sexual en Mujeres con Cáncer de Mama en Tratamiento con Hormonoterapia: Revisión Integradora de la Literatura. Revista Brasileira de Cancerologia 2026; 72(1) doi: 10.32635/2176-9745.RBC.2026v72n1.5333ES
|
| 38 |
Maya Ram-Weiner, Shani Paluch-Shimon, Tanir M. Allweis, Ahinoam Lev-Sagie. Vaginal health in breast cancer survivors: a practical clinical approach. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251344007
|
| 39 |
S. Palacios. Sequential treatment in vulvovaginal atrophy. Climacteric 2023; 26(4) doi: 10.1080/13697137.2023.2197588
|
| 40 |
Angelica Lindén Hirschberg. Enhancing quality of life: addressing vulvovaginal atrophy and urinary tract symptoms. Climacteric 2025; 28(4) doi: 10.1080/13697137.2025.2514029
|
| 41 |
Laura Ferreira de Rezende, Vanessa Fonseca Vilas Boas, Juliana Lenzi, Regiane Luz Carvalho. Evidence for the Use of Photobiomodulation in Sexual Dysfunction in Women with Breast Cancer Undergoing Hormone Therapy: Literature Integrative Review. Revista Brasileira de Cancerologia 2026; 72(1) doi: 10.32635/2176-9745.RBC.2026v72n1.5333EN
|
| 42 |
|
| 43 |
Amelia Favier, Marion Donnart, Eva Oueld Es Cheikh, Adeline Morisot, Catherine Uzan, Geoffroy Canlorbe. Long-term efficacy of CO2 fractional laser in the treatment of genitourinary syndrome of menopause. Journal of Gynecology Obstetrics and Human Reproduction 2025; 54(5) doi: 10.1016/j.jogoh.2025.102933
|
| 44 |
Pranjal Agrawal, Sajya M. Singh, Corey Able, Kathryn Dumas, Jaden Kohn, Taylor P. Kohn, Marisa Clifton. Safety of Vaginal Estrogen Therapy for Genitourinary Syndrome of Menopause in Women With a History of Breast Cancer. Obstetrics & Gynecology 2023; 142(3) doi: 10.1097/AOG.0000000000005294
|
| 45 |
James A Simon, Rossella E Nappi, Peter Chedraui, Amanda L Clark, Anne Gompel, Shaikh Zinnat Ara Nasreen, Santiago Palacios, Wendy Wolfman. Genitourinary syndrome of menopause (GSM): recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sexual Medicine Reviews 2026; 14(1) doi: 10.1093/sxmrev/qeaf055
|
| 46 |
Dana Siegel, Madeline Higgins, Cassandra Roeca, Sarah Tevis, Guluzar Arzu Turan, Elena Shagisultanova, Leslie Appiah. Preserving Fertility in Breast Cancer Care: Options and Considerations. Current Breast Cancer Reports 2025; 17(1) doi: 10.1007/s12609-025-00607-z
|
| 47 |
Maddalena Mallozzi. Vaginal treatment with solid state non ablative laser 1470 nm for vaginal atrophy in post menopausal women. Laser Therapy 2023; 30(1) doi: 10.4081/ltj.2023.320
|
| 48 |
Keila S. T. Ferreira, Nathalia S. Guimarães, Gisele V. de Oliveira. Efficacy of Erbium and CO2 Genital Laser Treatment on Genitourinary Syndrome in Female Patients After Breast Cancer: A Scoping Review. Lasers in Surgery and Medicine 2025; 57(5) doi: 10.1002/lsm.70027
|
| 49 |
Mekan R. Orazov, Elena S. Silantyeva, Viktor E. Radzinsky, Liudmila M. Mikhaleva, Elizaveta A. Khripach, Evgeny D. Dolgov. Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review. Gynecology 2023; 24(6) doi: 10.26442/20795696.2022.6.201897
|
| 50 |
Christina M. Wilson, Lisa S. Pair. Sexual Dysfunction in Patients With Breast or Gynecologic Cancer: What Women’s Healthcare Providers Need to Know. Clinical Journal for Nurse Practitioners in Women's Health 2024; 1(1) doi: 10.1891/CJNPWH-2421
|
| 51 |
Jissy Cyriac, Richa Sood. Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause. Clinics and Practice 2026; 16(3) doi: 10.3390/clinpract16030060
|
| 52 |
J. K. K. Mark, S. Samsudin, I. Looi, K. H. Yuen. Vaginal dryness: a review of current understanding and management strategies. Climacteric 2024; 27(3) doi: 10.1080/13697137.2024.2306892
|
| 53 |
Rossella E. Nappi, Silvia Martella, Francesca Albani, Chiara Cassani, Ellis Martini, Fabio Landoni. Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?. Healthcare 2022; 10(8) doi: 10.3390/healthcare10081528
|
| 54 |
Lotti Lúcia Lőczi, Gábor Vleskó, Máté Éliás, Caner Turan, Panna Kajtár, Réka Tóth, Miklós Sipos, Rita Nagy, Péter Hegyi, Nándor Ács, Szabolcs Várbíró, Márton Keszthelyi. Effect of Vaginal Laser and Topical Therapies on Vulvovaginal Atrophy Symptoms in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2024; 13(20) doi: 10.3390/jcm13206131
|
| 55 |
Fangfang Chen, Zhiyuan Bo, Yangfan Fan, Yizhou Huang, Yiding Chen, Fang Wan. Vaginal microbiota and genitourinary syndrome of menopause in premenopausal breast cancer patients receiving endocrine therapy: a longitudinal cohort study protocol. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1826064
|
| 56 |
Gilbert G.G. Donders, Francesca H.W.V. Donders. New developments in the management of vulvovaginal atrophy: a comprehensive overview. Expert Opinion on Pharmacotherapy 2023; 24(5) doi: 10.1080/14656566.2023.2194017
|
| 57 |
Nobuo Okui. Vaginal Laser Treatment for the Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Narrative Review. Cureus 2023; doi: 10.7759/cureus.45495
|
| 58 |
О.П. Матылевич, Л.Ф. Можейко.
Коррекция урогенитальных нарушений у женщин после проведения комплексного противоопухолевого лечения злокачественных новообразований органов малого таза: обзор литературы и перспективные направления
. Репродуктивное здоровье. Восточная Европа 2025; 15(6) doi: 10.34883/PI.2025.15.6.008
|
| 59 |
Feng Jing, Zheng Zhu, Jiajia Qiu, Lichen Tang, Lei Xu, Weijie Xing, Yan Hu. Symptom Clusters and Quality of Life in Patients With Breast Cancer Receiving Endocrine Therapy in China. Seminars in Oncology Nursing 2023; 39(4) doi: 10.1016/j.soncn.2023.151443
|
| 60 |
Mary E. Beste, Andrew M. Kaunitz, Jordan A. McKinney, Luis Sanchez-Ramos. Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks. American Journal of Obstetrics and Gynecology 2025; 232(3) doi: 10.1016/j.ajog.2024.10.054
|
| 61 |
Maliheh Arab, Mahshid Vasef, Maryam Talayeh, Maryam Sadat Hosseini, Farah Farzaneh, Tahereh Ashrafganjoei. The Effect of Radiofrequency Therapy on Sexual Function in Female Cancer Survivors (Gynecologic and Breast) and Non-cancer Menopausal Women: A Single-Arm Trial. Journal of Lasers in Medical Sciences 2023; 14 doi: 10.34172/jlms.2023.32
|
| 62 |
Gabriela C. Cantarelli, Ana M.H.M. Bianchi-Ferraro, Chayanne Dedonatto, Marcela F.R. Fernandes, Rafaela B. Vanzin, Rita C.M. Dardes, Angela F. Logullo, Joaquim S. de Almeida, Gil Facina, Zsuzsanna I.K. de Jármy-Di Bella, Marair G.F. Sartori, Marisa T. Patriarca. Clinical and histomorphometric evaluation of the vagina following treatment with CO2 laser, radiofrequency, and promestriene for genitourinary syndrome of menopause in breast cancer survivors on adjuvant therapy. Maturitas 2025; 191 doi: 10.1016/j.maturitas.2024.108155
|
| 63 |
Lucia Merlino, Giulia D’Ovidio, Viviana Matys, Maria Grazia Piccioni, Maria Grazia Porpora, Roberto Senatori, Maria Federica Viscardi, Antonio Vitale, Carlo Della Rocca. Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals 2023; 16(4) doi: 10.3390/ph16040550
|
| 64 |
Gaetano Perrini, Silvia Actis, Margherita Giorgi, Francesca Accomasso, Carola Minella, Cristina Fava, Giorgia Bisconte, Giovanni De Rosa, Annamaria Ferrero, Valentina Elisabetta Bounous. Assessment of the Efficacy and Safety of a Dual-Wavelength Diode Laser System for the Treatment of Vulvovaginal Atrophy in Women Without a History of Breast Cancer and in Patients with a History of Breast Cancer. Journal of Clinical Medicine 2025; 14(3) doi: 10.3390/jcm14030801
|
| 65 |
Risa Kagan, James A. Simon, Steven R. Goldstein, Barry S. Komm, Simon N. Jenkins, David J. Portman. Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials. Menopause 2024; 31(6) doi: 10.1097/GME.0000000000002355
|
| 66 |
Pasquale Marino, Roberta Colangelo, Paola Amendola, Ilaria Bochicchio, Alessandro Rocco Lettini, Stefania Lapadula, Alda Giuliano, Martina Catalano, Francesca Sanseverino. Oncosexology: A Narrative Review on Sexual Health and Quality of Life in Cancer Patients. Cancer Medicine 2026; 15(4) doi: 10.1002/cam4.71864
|
| 67 |
Shari B. Goldfarb, Sarah L. Sammons, Jane L. Meisel, Timothy J. Pluard, Simon N. Jenkins, Barry S. Komm, Dominic Carroll, David J. Portman. Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study. Clinical Breast Cancer 2025; 25(3) doi: 10.1016/j.clbc.2024.12.002
|
| 68 |
Sanja Brnić, Bruno Špiljak, Lucija Zanze, Ema Barac, Robert Likić, Liborija Lugović-Mihić. Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review. Biomedicines 2025; 13(8) doi: 10.3390/biomedicines13081901
|
| 69 |
Laura Ferreira de Rezende, Vanessa Fonseca Vilas Boas, Juliana Lenzi, Regiane Luz Carvalho. Evidências para o Uso da Fotobiomodulação para Disfunção Sexual em Mulheres com Câncer de Mama em Uso de Hormonioterapia: Revisão Integrativa da Literatura. Revista Brasileira de Cancerologia 2025; 72(1) doi: 10.32635/2176-9745.RBC.2026v72n1.5333
|
| 70 |
Pierre Marès, Camille Jauffret, Carine Martin, Patrice Lopes, Florence Coussy. Genitourinary syndrome of menopause in patients with breast cancer treated by hormonotherapy: women's perception in ITAC, a French web-based survey. Bulletin du Cancer 2024; 111(4) doi: 10.1016/j.bulcan.2023.08.014
|
| 71 |
Lauren F. Streicher. Diagnosis, causes, and treatment of dyspareunia in postmenopausal women. Menopause 2023; 30(6) doi: 10.1097/GME.0000000000002179
|
| 72 |
Haixiao Wen, Chong Lu, Meng Zhang, Xingling Qi. A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system. Expert Opinion on Drug Safety 2023; 22(11) doi: 10.1080/14740338.2023.2247971
|
| 73 |
Laurine Fabbro, Simon Leboube, Louise Moniod, Pascale Fabbro, Céline Chauleur. Evaluation of symptom improvement over time after fractional CO2 laser therapy in women with genito-urinary syndrome. Journal of Gynecology Obstetrics and Human Reproduction 2026; 55(4) doi: 10.1016/j.jogoh.2026.103121
|
| 74 |
Penny Kechagioglou, Nina Fuller-Shavel. Integrative Oncology in Breast Cancer Care. 2023; doi: 10.1007/978-3-031-51216-2_8
|
| 75 |
Nobuo Okui, Machiko Okui, Yuko Kouno, Kaori Nakano, Marco Gambacciani. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause. Cureus 2023; doi: 10.7759/cureus.38604
|
| 76 |
Yueh‐Ching Lee, Yuan‐Ching Chang, Cheng‐Chen Chou, Yen‐Kuang Lin, Chia‐Hui Li, Yuan‐Mei Liao. Psychometric Evaluation of the Chinese Version of the Vulvovaginal Symptom Questionnaire in Women With Breast Cancer. Journal of Advanced Nursing 2025; 81(7) doi: 10.1111/jan.16584
|
| 77 |
Roxana Popescu, Corina Flangea, Daliborca Cristina Vlad, Ionut Marcel Cobec, Peter Seropian, Cristina Doriana Marina, Tania Vlad, Andrei Luca Dumitrascu, Daniela Puscasiu. Nutritional Impact on Breast Cancer in Menopausal and Post-Menopausal Patients Treated with Aromatase Inhibitors. Cancers 2025; 18(1) doi: 10.3390/cancers18010073
|
| 78 |
Iman Akef Khowailed, Ibrahim M. Moustafa, Haneul Lee. The effectiveness of pelvic rehabilitation Program on genitourinary syndrome in a breast cancer survivor: a case report. Physiotherapy Theory and Practice 2025; 41(12) doi: 10.1080/09593985.2025.2532575
|
| 79 |
Marcia Farina Kamilos. Síndrome geniturinária após câncer de mama e radioterapia pélvica: abordagens terapêuticas baseadas em evidências. Revista Brasileira de Patologia do Trato Genital Inferior 2026; 9(2) doi: 10.5327/2237-4574-134
|
| 80 |
Vera N. Prilepskaya, Niso M. Nazarova, Anastasia R. Devyatkina, Patimat R. Abakarova, Elena A. Mezhevitinova. Potential and perspectives of local application of hyaluronic acid in vulvovaginal atrophy in women of reproductive age: A review. Gynecology 2024; 26(3) doi: 10.26442/20795696.2024.3.202932
|
| 81 |
Ana Lozano-Rubio, Cristina Salar-Andreu, Sergio Montero-Navarro, Marie Riquier, Francisco J. Molina-Payá, María Torres-Lacomba, Josep C. Benítez-Martínez, Jesús Sánchez-Más, Cristina Orts-Ruiz. Exploring the unseen consequences: effects of cancer treatment on pelvic health and quality of life in breast cancer survivors—a matched cross-sectional observational study. Supportive Care in Cancer 2026; 34(2) doi: 10.1007/s00520-026-10324-7
|